Literature DB >> 19267409

Fibroblast growth factor-9 inhibits astrocyte differentiation of adult mouse neural progenitor cells.

Maggie Lum1, Alisa Turbic, Branka Mitrovic, Ann M Turnley.   

Abstract

Fibroblast growth factor-9 (FGF9) is expressed in the CNS and is reported to be a mitogen for glial cells, to promote neuronal survival, and to retard oligodendrocyte differentiation. Here we examined the effects of FGF9 on the differentiation, survival, and proliferation of adult neural progenitor cells derived from the adult mouse subventricular zone. FGF9 by itself induced neurosphere proliferation, but its effects were modest compared with those of epidermal growth factor and FGF2. When neurospheres were dissociated and plated for differentiation, FGF9 increased total cell number over time in a dose-dependent manner. Ki67 immunostaining and bromodeoxyuridine incorporation indicated that this was at least partially due to the continued presence of proliferative nestin-positive neural progenitor cells and betaIII tubulin-positive neuronal precursors. FGF9 also promoted cell survival as indicated by a decreased number of TUNEL-positive cells over time. Assessment of differentiation showed that FGF9 increased neuron generation that reflected the increase in total cell number; however, the percentage of progenitor cells differentiating into neurons was slightly decreased. FGF9 had a modest effect on oligodendrocyte generation, although it appeared to slow the maturation of oligodenrocytes at higher concentrations. The most marked effect on differentiation was an almost total lack of glial fibrillary acidic protein (GFAP)-positive astrocytes up to 7 days following FGF9 addition, indicating that astrocyte differentiation was strongly inhibited. Total inhibition required prolonged treatment, although a 1-hr pulse was sufficient for partial inhibition, and bone morphogenic protein-4 could partially overcome the FGF9 inhibition of astrocyte differentiation. FGF9 therefore has multiple effects on adult neural precursor cell function, enhancing neuronal precursor proliferation and specifically inhibiting GFAP expression. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19267409     DOI: 10.1002/jnr.22047

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  13 in total

1.  Fgf9 Y162C Mutation Alters Information Processing and Social Memory in Mice.

Authors:  Lillian Garrett; Lore Becker; Jan Rozman; Oliver Puk; Tobias Stoeger; Ali Önder Yildirim; Alexander Bohla; Oliver Eickelberg; Wolfgang Hans; Cornelia Prehn; Jerzy Adamski; Thomas Klopstock; Ildikó Rácz; Andreas Zimmer; Martin Klingenspor; Helmut Fuchs; Valerie Gailus-Durner; Wolfgang Wurst; Martin Hrabě de Angelis; Jochen Graw; Sabine M Hölter
Journal:  Mol Neurobiol       Date:  2017-07-10       Impact factor: 5.590

2.  Fibroblast growth factor 9 is a novel modulator of negative affect.

Authors:  Elyse L Aurbach; Edny Gula Inui; Cortney A Turner; Megan H Hagenauer; Katherine E Prater; Jun Z Li; Devin Absher; Najmul Shah; Peter Blandino; William E Bunney; Richard M Myers; Jack D Barchas; Alan F Schatzberg; Stanley J Watson; Huda Akil
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-08       Impact factor: 11.205

Review 3.  New insights into the role of fibroblast growth factors in Alzheimer's disease.

Authors:  Ramy Alam; Yara Mrad; Hussein Hammoud; Zahraa Saker; Youssef Fares; Elias Estephan; Hisham F Bahmad; Hayat Harati; Sanaa Nabha
Journal:  Mol Biol Rep       Date:  2021-11-03       Impact factor: 2.316

4.  Stable expression of neurogenin 1 induces LGR5, a novel stem cell marker, in an immortalized human neural stem cell line HB1.F3.

Authors:  Jun-ichi Satoh; Shinya Obayashi; Hiroko Tabunoki; Taeko Wakana; Seung U Kim
Journal:  Cell Mol Neurobiol       Date:  2009-10-08       Impact factor: 5.046

Review 5.  Roles of Fibroblast Growth Factors and Their Therapeutic Potential in Treatment of Ischemic Stroke.

Authors:  Confidence Dordoe; Keyang Chen; Wenting Huang; Jun Chen; Jian Hu; Xue Wang; Li Lin
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

6.  Gene expression profiling of embryonic human neural stem cells and dopaminergic neurons from adult human substantia nigra.

Authors:  Hany E S Marei; Asma Althani; Nahla Afifi; Fabrizio Michetti; Mario Pescatori; Roberto Pallini; Patricia Casalbore; Carlo Cenciarelli; Philip Schwartz; Abd-Elmaksoud Ahmed
Journal:  PLoS One       Date:  2011-12-07       Impact factor: 3.240

7.  FGF9 from cancer-associated fibroblasts is a possible mediator of invasion and anti-apoptosis of gastric cancer cells.

Authors:  Chao Sun; Hirokazu Fukui; Ken Hara; Xinxing Zhang; Yoshitaka Kitayama; Hirotsugu Eda; Toshihiko Tomita; Tadayuki Oshima; Shojiro Kikuchi; Jiro Watari; Mitsuru Sasako; Hiroto Miwa
Journal:  BMC Cancer       Date:  2015-04-30       Impact factor: 4.430

8.  Tuning of neocortical astrogenesis rates by Emx2 in neural stem cells.

Authors:  Carmen Falcone; Antonello Mallamaci
Journal:  Neural Regen Res       Date:  2015-04       Impact factor: 5.135

9.  miR-182 inhibits Schwann cell proliferation and migration by targeting FGF9 and NTM, respectively at an early stage following sciatic nerve injury.

Authors:  Bin Yu; Tianmei Qian; Yongjun Wang; Songlin Zhou; Guohui Ding; Fei Ding; Xiaosong Gu
Journal:  Nucleic Acids Res       Date:  2012-08-23       Impact factor: 16.971

Review 10.  Adult subventricular zone neural stem cells as a potential source of dopaminergic replacement neurons.

Authors:  John W Cave; Meng Wang; Harriet Baker
Journal:  Front Neurosci       Date:  2014-02-10       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.